We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

141 hedge funds and large institutions have $297M invested in SANGAMO THERAPEUTICS INC in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 34 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

632% more call options, than puts

Call options by funds: $17.6M | Put options by funds: $2.41M

68% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 34

10% less funds holding

Funds holding: 156141 (-15)

43% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 35

47% less capital invested

Capital invested by funds: $560M → $297M (-$263M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
141
Holders Change
-15
Holders Change %
-9.62%
% of All Funds
3.94%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
57
Reduced
34
Closed
35
Calls
$17.6M
Puts
$2.41M
Net Calls
+$15.2M
Net Calls Change
-$122M
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$2.33M +$17.6K +2,140 +0.5%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.3M +$1.81M +219,596 +117%
Morgan Stanley
28
Morgan Stanley
New York
$2.24M -$23.4K -2,835 -0.7%
CAM
29
Cormorant Asset Management
Massachusetts
$2.04M
TCIM
30
TIAA CREF Investment Management
New York
$1.8M -$124K -15,005 -4%
CS
31
Credit Suisse
Switzerland
$1.77M -$812K -98,515 -24%
TAM
32
Tocqueville Asset Management
New York
$1.72M -$1.29M -156,620 -34%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$1.71M +$1.04M +126,654 +72%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.59M +$1.48M +179,312 +173%
BA
35
BlackRock Advisors
Delaware
$1.52M +$779K +94,511 +54%
SCM
36
Suffolk Capital Management
New York
$1.42M +$444K +53,885 +27%
BIM
37
BlackRock Investment Management
Delaware
$1.3M -$27.8K -3,370 -1%
OAM
38
Oxford Asset Management
United Kingdom
$1.24M +$353K +42,856 +24%
RA
39
Royce & Associates
New York
$1.2M +$1.75M +212,100 New
Charles Schwab
40
Charles Schwab
California
$1.14M -$118K -14,320 -7%
CA
41
Commerzbank Aktiengesellschaft
Germany
$1.14M +$1.66M +201,577 New
First Eagle Investment Management
42
First Eagle Investment Management
New York
$1.13M +$1.65M +200,000 New
Wells Fargo
43
Wells Fargo
California
$952K +$119K +14,375 +9%
TA
44
Teachers Advisors
New York
$854K -$2.12M -256,819 -63%
QI
45
QS Investors
New York
$819K
Ohio Public Employees Retirement System (OPERS)
46
Ohio Public Employees Retirement System (OPERS)
Ohio
$802K +$363K +44,008 +45%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$787K
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$714K -$3.3K -400 -0.3%
PCMI
49
Princeton Capital Management Inc
New Jersey
$685K +$60.4K +7,325 +6%
AllianceBernstein
50
AllianceBernstein
Tennessee
$601K -$1.07K -130 -0.1%

SGMO Hedge Fund Activity: Q3 2015 in Review

141 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2015, worth a combined $297M — down 47% from $560M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of SGMO and 20 opened new positions — a net loss of 15 holders — while 34 trimmed existing stakes and 57 added.

The largest buyer was Wasatch Advisors, adding an estimated $30.8M. The largest seller was Jennison Associates, exiting entirely with an estimated $19.2M sold.

  • 141 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2015, down from 156 in Q2 2015.
  • Funds reported $297M of SANGAMO THERAPEUTICS INC stock for Q3 2015, down 47% quarter-over-quarter.
  • 20 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2015 and 35 closed out, a net change of -15 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2015 was Wasatch Advisors, an estimated $30.8M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2015 was Jennison Associates, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2015.